Search

Search Constraints

You searched for: Subject 616.6005 Issue Volume 13(2021)

Search Results

2. Antiangiogenic tyrosine kinase inhibitors and immunotherapy as first-line treatment for metastatic renal cell carcinoma: is there an increased risk of hypothyroidism?. (July 2021)